Sign in to continue:

Wednesday, July 29th, 2026

Southern Cross Acquisition I Corp. Faces Going Concern Doubts After $115M IPO – Audited Financial Overview 2026

Southern Cross Acquisition I Corp. Issues Audited Balance Sheet and Financial Statements: Key Details for Investors

Southern Cross Acquisition I Corp. (“SXGC”) has released its audited balance sheet as of July 22, 2026, along with comprehensive financial statements and notes. This Special Purpose Acquisition Corporation (SPAC), incorporated in the Cayman Islands, was formed to execute a business combination within 12 months of its initial public offering (IPO). Below are critical highlights and price-sensitive details that shareholders and investors must know.

Key Financial Highlights

  • Total Assets: \$115,705,290, including \$115 million held in a U.S.-based Trust Account, earmarked for a future business combination.
  • Current Assets: \$705,290, comprised of \$645,899 in cash and \$59,391 in prepaid expenses.
  • Current Liabilities: \$119,860, including \$83,560 in accrued expenses and \$36,300 in other payable to related parties.
  • Deferred Underwriting Commission: \$1,150,000 payable upon consummation of a business combination.
  • Shareholders’ Equity: Negative \$564,570, primarily due to accumulated deficit and transaction costs.

SPAC Structure and IPO Details

  • On July 22, 2026, SXGC completed its IPO, issuing 11,500,000 units (including full exercise of the over-allotment option), raising gross proceeds of \$115,000,000.
  • Each unit includes one ordinary share, one right to receive one-fourth of an ordinary share, and one redeemable warrant to purchase an ordinary share at \$11.50.
  • Simultaneously, the Sponsor purchased 239,300 identical private units for \$2,393,000 in a private placement.
  • The proceeds from the IPO and private placement were deposited into a Trust Account, and will be used solely for the business combination or returned to shareholders if no combination occurs within the mandated period.

Going Concern Warning: Critical Shareholder Alert

SXGC’s auditors have issued a “substantial doubt” warning regarding the company’s ability to continue as a going concern. The SPAC must complete a business combination within 12 months of the IPO (July 22, 2027), or it will wind up and redeem all public shares. The company currently has no operating revenues and relies solely on the funds raised. If it fails to secure a deal or extend its deadline, shareholders may see their investment returned at redemption value, and the share price could be impacted significantly.

Redemption and Liquidation Provisions

  • Public shares are subject to redemption at \$10.00 per share if no business combination is completed.
  • Funds in the Trust Account will be used for redemption, with no liquidation rights for warrants or rights.
  • The mandatory liquidation date is less than one year from the financial statement issuance date, raising substantial doubt about the company’s future.

Share-Based Compensation and Related Party Transactions

  • Founder Shares were transferred to officers and directors at a discounted price, representing a total fair value of \$47,040 (\$3.36 per share), accounted for under share-based compensation rules.
  • All advances and loans from the Sponsor were settled or reclassified post-IPO. The Sponsor and insiders may provide Working Capital Loans or Extension Loans, convertible into units at \$10.00 each, but are not obligated to do so.
  • No Working Capital Loans or Extension Loans were outstanding as of July 22, 2026.

Equity Structure & Lock-Up Agreements

  • Ordinary shares and preferred shares are authorized; 3,229,300 ordinary shares are issued and outstanding (excluding the 11.5 million subject to redemption).
  • Founder Shares, Private Shares, and Representative Shares have voting and lock-up restrictions, ensuring alignment with public shareholders during a business combination vote.

Warrants and Rights Instruments

  • 11,500,000 Public Warrants and 239,300 Private Warrants outstanding; exercisable at \$11.50 per share, subject to various redemption and adjustment clauses.
  • 11,500,000 Public Rights and 239,300 Private Rights outstanding; each entitles the holder to one-fourth of an ordinary share upon completion of a business combination.
  • Both instruments expire worthless if no deal is completed within the deadline.

Commitments, Contingencies, and Risks

  • SXGC faces risks related to its ability to consummate a transaction, including market volatility, liquidity constraints, and macroeconomic factors.
  • The company has entered into registration rights agreements for insider securities and pays underwriting commissions contingent on deal completion.

Accounting Policies & Recent Developments

  • SXGC is classified as an “emerging growth company” under the JOBS Act, allowing for certain reporting exemptions and delayed adoption of new accounting standards.
  • Recent FASB pronouncements (ASU 2023-06, ASU 2024-03, ASU 2024-04) will impact disclosure and accounting for expenses and convertible debt in future periods.

Segment Information

  • SXGC operates as a single segment, with the Chief Executive Officer serving as the chief operating decision maker, reviewing cash, prepaid expenses, and Trust Account balances to assess liquidity and performance.

Subsequent Events

  • Management reviewed subsequent events through July 28, 2026; no material events impacting financial statements were identified.

Potential Price-Sensitive Issues

  • Going Concern Warning: If SXGC fails to secure a business combination or extend its deadline, shareholders may only receive their redemption value, and all warrants and rights may expire worthless. This scenario would likely impact the share price negatively.
  • Deadline for Combination: Investors should monitor progress toward a business combination and any extensions, as failure to meet the deadline could trigger liquidation.
  • Insider Loans and Conversions: Any new loans or conversions by insiders may affect the capital structure and dilution.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the full financial statements, consult with their advisors, and consider all risks before making investment decisions. The information presented reflects the company’s financial status as of July 22, 2026, and may be subject to change.

View Southern Cross Acquisition I Corp. Historical chart here



Federated Hermes Acquires 80% Stake in FCP Fund Manager to Expand US Real Estate and Alternatives Platform

Federated Hermes Completes Acquisition of 80% Stake in FCP F...

Caris Life Sciences 2025 Annual Report: Precision Oncology, Molecular Profiling, AI/ML Innovation, and Business Overview

Caris Life Sciences, Inc. 2025 Annual Report – Key Highlight...

Femasys Inc. Enters Omnibus Amendment and Issues Series D-1 Warrants – SEC 8-K Filing March 2026

Femasys Inc. Issues 8-K: Series D-1 Warrants and Omnibus Ame...